Abstract:Objective: To explore the role of tumor necrosis factor receptor-associated factor 4 (TRAF4) in promoting the abnormal activation of epidermal growth factor receptor (EGFR) and its effect on lung cancer cell proliferation, migration and invasion. Methods: Tumor tissues from patients who underwent lung adenocarcinoma resection at The First Affiliated Hospital of Second Military Medical University, from January 2015 to May 2017 were collected, and the expressions of TRAF4 and Ki-67 in lung cancer tissues were detected by immunohistochemistry, the mRNA levels of Cyclin D and Vimentin were detected by real-time fluorescence quantitative PCR (qRT-PCR). The effect of TRAF4 on the tumor growth ability of lung cancer A549 cells was investigated by the xenograft model, the effect of TRAF4 or EGFR on the tumor proliferation ability was detected by using cell counting kit 8 (CCK8) and BrdU assay, and the migration and invasion abilities of tumor cells were detected by Transwell assay. Different structural domain deletion expression vectors of TRAF4 and EGFR were constructed to transfect cells, and the interaction mode of TRAF4 and EGFR was investigated by immunoprecipitation assay. Results: The expression of TRAF4 in non-small cell lung cancer (NSCLC) tissues was positively correlated with the expressions of Ki-67, cyclin D, and vimentin (r2: 0.438, 0.695, and 0.736, respectively, all P＜0.01). Immunohistochemical assay of tumor tissues from NSCLC patients showed that tissues with high expression of TRAF4 were also high in Ki-67. Patients with high TRAF4 expression (TRAF4 positivity >30%) had a shorter progression-free survival (PFS) time than that of patients with low TRAF4 expression (TRAF4 positivity ≤30%) (median PFS of 12 and 19 months, respectively; P=0.034). Traf4-/- cells had a weakened proliferative capacity than traf4+/+ cells and formed tumors with smaller size (P＜0.05). The expression level of Ki-67 in the tumor tissues formed by traf4-/- cells [(45.6±8.7)%] was lower than that in the tumor tissues formed by traf4+/+ cells [(62.3±10.3)%, P=0.015], the mRNA levels of cyclin D (1.01±0.15) and vimentin (1.01±0.12) in the traf4-/- cells were lower than those of the traf4+/+ cells (3.41±0.32 and 3.12±0.18, respectively, both P＜0.05).The western blot results showed that, with the elevated intracellular expression level of TRAF4, phosphorylation level of EGFR was significantly increased in both wild-type EGFR and activation mutant EGFR-expression cells. The capacities of proliferation, migration and invasion of A549 cells was weakened after EGFR knockdown (all P＜0.01). Immunoprecipitation experiments showed that TRAF4 binds to the peptide segment of the near-membrane region of EGFR through the TRAF structural domain, and the mutual binding between EGFR molecules was enhanced under TRAF4 overexpression conditions. Increasing TRAF4 expression promoted EGFR molecular phosphorylation and activation of downstream signaling. Conclusions: TRAF4 expression is elevated in NSCLC tissues and tumor cells, which promotes tumor proliferation, migration and invasion. TRAF4 directly binds to EGFR molecules, enhances its own phosphorylation and activates the downstream signaling pathway by promoting the interaction between EGFR molecules.

TRAF6 Promoted the Tumorigenicity of Esophageal Squamous Cell Carcinoma

High TRAF6 Expression is Associated with Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion.

TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.

TRAF6 Regulates EGF-induced Cell Transformation and Cscc Malignant Phenotype Through CD147/EGFR

TRAF6 is Over-Expressed in Pancreatic Cancer and Promotes the Tumorigenicity of Pancreatic Cancer Cells

TRAF6 is Upregulated in Colon Cancer and Promotes Proliferation of Colon Cancer Cells

Tumor Necrosis Factor Receptor-Associated Factor 6 Contributes to Malignant Behavior of Human Cancers Through Promoting AKT Ubiquitination and Phosphorylation

TRAF6 Promotes the Invasion and Metastasis and Predicts a Poor Prognosis in Gastric Cancer.

TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms

TRAF6 Inhibits Colorectal Cancer Metastasis Through Regulating Selective Autophagic CTNNB1/β-catenin Degradation and is Targeted for GSK3B/GSK3β-mediated Phosphorylation and Degradation.

TRAF6 Regulates YAP Signaling by Promoting the Ubiquitination and Degradation of MST1 in Pancreatic Cancer

Effect of TRAF6 Downregulation on Malignant Biological Behavior of Lung Cancer Cell Lines]

The Role of TMEM26 in Disrupting Tight Junctions and Activating NF-κB Signaling to Promote Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6

Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.

TRAF6 Activates Fibroblasts to Cancer-Associated Fibroblasts through FGF19 in Tumor Microenvironment to Benefit the Malignant Phenotype of Melanoma Cells

The Expression of Chemokine Receptor 6 in Esophageal Cancer Tissue and Its Effects on Epithelial-to-mesenchymal Transition

HOXC6 Promotes Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells Via Modulating Expression of Genes Involved in Malignant Phenotypes

[TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR]

The relationship between TRAF6 and tumors

Overexpression of TRAF4 promotes lung cancer growth and EGFR-dependent phosphorylation of ERK5